Structured evidence table for Algal Oil Triglycerides Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Algal Oil Triglycerides Meta-Analysis | 8 9 6 10 11 12–14 1 15 16 15 2 16 17 18 Most of the increased morbidity and mortality associated with CKD is attributable to CVD [,] with an increased risk beginning with both mildly reduced estimated glomerular filtration rate (eGFR) and very low levels of albuminuria (albumin: creatinine ratio >30 mg/g). | 3 | Ferro Charles J (2026) | Fish oil supplements in patients with chronic kidney disease |
| Algal Oil Triglycerides Meta-Analysis | This risk increases exponentially and independently with worsening eGFR and albuminuria with the highest risk being observed in individuals with severely reduced eGFR and high levels of albuminuria [,,]. | 3 | Ferro Charles J (2026) | Fish oil supplements in patients with chronic kidney disease |
| Algal Oil Triglycerides Meta-Analysis | Not surprisingly, kidney failure, the most extreme category of CKD, is associated with the highest cardiovascular risk []. | 3 | Ferro Charles J (2026) | Fish oil supplements in patients with chronic kidney disease |
| Algal Oil Triglycerides Meta-Analysis | 1–5 4–7 Chronic kidney disease (CKD) is a major global health priority estimated to affect 13% of adults worldwide including close to 100 million Europeans, and projected to increase rapidly over the next decades []. | 3 | Ferro Charles J (2026) | Fish oil supplements in patients with chronic kidney disease |
| Algal Oil Triglycerides Meta-Analysis | This study explored the influence DHA-rich microalgae oil might have on genes and metabolites associated with lipid and glucose metabolism in NAFLD mice, offering promising insights into a novel, cost-effective treatment for NAFLD. | 4 | AlQahtani A (2026) | Microalgae Oil Attenuates Liver Fat Deposition in NAFLD via Modulation of Anti-Lipogenic Genes and Insulin Signaling Pathways in HFD Mice. |
| Algal Oil Triglycerides Meta-Analysis | The increase in liver weight induced by HFD was partially reduced by 7% in microalgae oil-treated mice. | 4 | AlQahtani A (2026) | Microalgae Oil Attenuates Liver Fat Deposition in NAFLD via Modulation of Anti-Lipogenic Genes and Insulin Signaling Pathways in HFD Mice. |
| Algal Oil Triglycerides Meta-Analysis | Furthermore, microalgae oil treatment was associated with a downregulation of the PPAR and PI3K-Akt signaling pathways, which were found to be enriched in the HFD-fed group. | 4 | AlQahtani A (2026) | Microalgae Oil Attenuates Liver Fat Deposition in NAFLD via Modulation of Anti-Lipogenic Genes and Insulin Signaling Pathways in HFD Mice. |
| Algal Oil Triglycerides Meta-Analysis | Non-alcoholic fatty liver disease (NAFLD) is a leading cause of liver-related mortality and morbidity globally, with its prevalence steadily rising. | 4 | AlQahtani A (2026) | Microalgae Oil Attenuates Liver Fat Deposition in NAFLD via Modulation of Anti-Lipogenic Genes and Insulin Signaling Pathways in HFD Mice. |
Source documents